These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 32769058
1. Carbazole derivatives containing chalcone analogues targeting topoisomerase II inhibition: First principles characterization and QSAR modelling. Ghamri M, Harkati D, Belaidi S, Boudergua S, Said RB, Linguerri R, Chambaud G, Hochlaf M. Spectrochim Acta A Mol Biomol Spectrosc; 2020 Dec 05; 242():118724. PubMed ID: 32769058 [Abstract] [Full Text] [Related]
2. Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers. Li PH, Jiang H, Zhang WJ, Li YL, Zhao MC, Zhou W, Zhang LY, Tang YD, Dong CZ, Huang ZS, Chen HX, Du ZY. Eur J Med Chem; 2018 Feb 10; 145():498-510. PubMed ID: 29335211 [Abstract] [Full Text] [Related]
3. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives. Na Y, Nam JM. Bioorg Med Chem Lett; 2011 Jan 01; 21(1):211-4. PubMed ID: 21115246 [Abstract] [Full Text] [Related]
4. QSAR of Chalcones Utilizing Theoretical Molecular Descriptors. Nandi S, Bagchi MC. Curr Comput Aided Drug Des; 2015 Jan 01; 11(2):184-93. PubMed ID: 26135340 [Abstract] [Full Text] [Related]
5. Development of 2D, 3D-QSAR and Pharmacophore Modeling of Chalcones for the Inhibition of Monoamine Oxidase B. Mathew B, Herrera-Acevedo C, Dev S, Rangarajan TM, Kuruniyan MS, Naseef PP, Scotti L, Scotti MT. Comb Chem High Throughput Screen; 2022 Jan 01; 25(10):1731-1744. PubMed ID: 34397324 [Abstract] [Full Text] [Related]
6. Palindromic carbazole derivatives: unveiling their antiproliferative effect via topoisomerase II catalytic inhibition and apoptosis induction. Olszewski M, Maciejewska N, Kallingal A, Chylewska A, Dąbrowska AM, Biedulska M, Makowski M, Padrón JM, Baginski M. J Enzyme Inhib Med Chem; 2024 Dec 01; 39(1):2302920. PubMed ID: 38221785 [Abstract] [Full Text] [Related]
7. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα. Alam S, Khan F. Drug Des Devel Ther; 2014 Dec 01; 8():183-95. PubMed ID: 24516330 [Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors. Jiang H, Zhang WJ, Li PH, Wang J, Dong CZ, Zhang K, Chen HX, Du ZY. Bioorg Med Chem Lett; 2018 May 01; 28(8):1320-1323. PubMed ID: 29545100 [Abstract] [Full Text] [Related]
9. Quantitative structure-activity relationships of mosquito larvicidal chalcone derivatives. Pasquale G, Romanelli GP, Autino JC, García J, Ortiz EV, Duchowicz PR. J Agric Food Chem; 2012 Jan 18; 60(2):692-7. PubMed ID: 22217234 [Abstract] [Full Text] [Related]
10. 20-(S)-camptothecin analogues as DNA topoisomerase I inhibitors: a QSAR study. Hansch C, Verma RP. ChemMedChem; 2007 Dec 18; 2(12):1807-13. PubMed ID: 17886246 [Abstract] [Full Text] [Related]
11. Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity. Abdel-Aziz M, Park SE, Abuo-Rahma Gel-D, Sayed MA, Kwon Y. Eur J Med Chem; 2013 Nov 18; 69():427-38. PubMed ID: 24090914 [Abstract] [Full Text] [Related]
12. A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study. Karki R, Jun KY, Kadayat TM, Shin S, Thapa Magar TB, Bist G, Shrestha A, Na Y, Kwon Y, Lee ES. Eur J Med Chem; 2016 May 04; 113():228-45. PubMed ID: 26945111 [Abstract] [Full Text] [Related]
13. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway. Marquina S, Maldonado-Santiago M, Sánchez-Carranza JN, Antúnez-Mojica M, González-Maya L, Razo-Hernández RS, Alvarez L. Bioorg Med Chem; 2019 Jan 01; 27(1):43-54. PubMed ID: 30482548 [Abstract] [Full Text] [Related]
14. The topoisomerase II β -kinase associated with HIV-1 is a potential target for pyridine-bischalcones' anti-HIV-1 activity. Kammari K, Devaraya K, Swain S, Kondapi AK. Eur J Med Chem; 2023 Nov 05; 259():115623. PubMed ID: 37473689 [Abstract] [Full Text] [Related]
15. Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor. Jun KY, Kwon H, Park SE, Lee E, Karki R, Thapa P, Lee JH, Lee ES, Kwon Y. Eur J Med Chem; 2014 Jun 10; 80():428-38. PubMed ID: 24796883 [Abstract] [Full Text] [Related]
16. Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study. Ivković BM, Nikolic K, Ilić BB, Žižak ŽS, Novaković RB, Čudina OA, Vladimirov SM. Eur J Med Chem; 2013 May 10; 63():239-55. PubMed ID: 23501110 [Abstract] [Full Text] [Related]
17. Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors. Ibrahim MK, Taghour MS, Metwaly AM, Belal A, Mehany ABM, Elhendawy MA, Radwan MM, Yassin AM, El-Deeb NM, Hafez EE, ElSohly MA, Eissa IH. Eur J Med Chem; 2018 Jul 15; 155():117-134. PubMed ID: 29885574 [Abstract] [Full Text] [Related]
18. Synthesis and antiproliferative activity of some ellipticine-like 11H-pyrido[a]carbazole derivatives. Ferlin MG, Gia O, Dalla Via L. ChemMedChem; 2011 Oct 04; 6(10):1872-83. PubMed ID: 21826796 [Abstract] [Full Text] [Related]
19. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents. Kim SH, Lee E, Baek KH, Kwon HB, Woo H, Lee ES, Kwon Y, Na Y. Bioorg Med Chem Lett; 2013 Jun 01; 23(11):3320-4. PubMed ID: 23608763 [Abstract] [Full Text] [Related]
20. Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines. Sangpheak K, Mueller M, Darai N, Wolschann P, Suwattanasophon C, Ruga R, Chavasiri W, Seetaha S, Choowongkomon K, Kungwan N, Rungnim C, Rungrotmongkol T. J Enzyme Inhib Med Chem; 2019 Dec 01; 34(1):134-143. PubMed ID: 30394113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]